arches trial: enzalutamide plus adt for mhspc
Published 3 years ago • 148 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
2:18
arches: enzalutamide plus adt in mhspc subgroups
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer
-
5:11
enzalutamide adt in men with de novo mhspc: the arches trial
-
6:00
arches trial
-
3:03
arches post-hoc analyses: efficacy of enza adt in mhspc by pattern of metastatic spread
-
17:02
androgen deprivation therapy and prostate cancer
-
7:49
prostate cancer recurrence in pelvic lymph nodes (high-indigo stage) | prostate cancer staging guide
-
15:33
standard treatment for advanced prostate cancer
-
1:35
arches: os by high or low disease volume and progression to mhspc or de novo mhspc
-
6:02
update on the arches trial: new indication for enzalutamide in mhspc
-
3:57
update on arches trial: implications for prostate cancer treatment
-
1:37
arches: os in mhspc who recieved prior adt and reached low psa further treated with enzalutamide
-
3:18
arches: radiographic progression in the absence of psa progression in patients with mhspc
-
1:30
final os analysis from arches
-
2:04
update on overall survival in arches trial
-
6:26
enzamet & arches trials provides evidence of enzalutamide as life prolonging therapy in mhspc
-
3:43
arches trial: androgen deprivation therapy with enzalutamide or placebo in mhspc
-
1:03
dr. azad on the benefit of adding enzalutamide to adt in mhspc
-
6:06
enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
-
2:17
enzalutamide for biochemically recurrent prostate cancer | nejm
-
3:06
titan trial
-
1:03
dr. zhang on the arches trial in prostate cancer